ARCHIVES

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004

Still Misperceptions On Hill About CRADA Between NCI, BMS

March 13, 1992

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

In Brief: DRCA Board Split On Guidelines For CCOP Remains Unresolved; Chop Implementation Talks Starting

December 4, 1981